Prostatype Genomics presents Quarterly Report
Prostatype Genomics AB has today published its quarterly report for the first quarter comprising the period from 1 January 2022 to 31 March 2022. The report is available on the company website.Quarter 1 (1 March – 31 March 2022) summarized · Net sales amounted to 264 TSEK. · Net revenue amounted to 260 TSEK. · EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to – 5 050 TSEK. · Cash flow from current operations in the quarter amounted -5 802 TSEK. · Total cash flow for the period amounted to -5 903 TSEK. · Earnings per share amounted to -0,